The Association between High-Dose Allopurinol and Erythropoietin Hyporesponsiveness in Advanced Chronic Kidney Disease: JOINT-KD Study

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Kidney Failure 100%
• Erythropoietin 100%
• Allopurinol 100%
• Treatment Group 44%
• Febuxostat 33%
• Urate 22%
• Hemodialysis 11%
• Antianemic Agent 11%

Biochemistry, Genetics and Molecular Biology

• Drug Megadose 100%
• Erythropoietin 100%
• Allopurinol 100%
• Low Drug Dose 33%
• Febuxostat 33%
• Glomerulus Filtration 11%
• Erythropoiesis-Stimulating Agent 11%
• Hemodialysis 11%
• Peritoneal Dialysis 11%

Immunology and Microbiology

• Drug Megadose 100%
• Allopurinol 100%
• Erythropoietin 100%
• Low Drug Dose 33%
• Optimal Drug Dose 11%
• Glomerulus Filtration 11%
• Organ Transplantation 11%
• Hemodialysis 11%
• Peritoneal Dialysis 11%